Stock Prediction and Forecast [RKLB]

AI-generated source summary

Rocket Lab (RKLB) stock has been ranked as 'Hold/Accumulate' since December 18, 2025, yielding a 46.79% gain over 23 days. The short-term trend indicates a robust rising channel, projecting a potential price change of approximately 65.86% over three months, with a possible return ranging from 23.88% to 85.21%. The 12-month analysis points to a projected change of about 143.77%, with price targets between $117.93 and $236.43. The last trading day, January 22, 2026, saw a 0.108% increase, closing at $87.96, with a daily fluctuation of 9.89%. Technical indicators present mixed signals; MACD shows a buy, while short-term Moving Average indicates a sell. Long-term Moving Averages and their crosses suggest buy signals. Resistance is observed at $90.06 (short-term MA) and support at $71.18 (long-term MA). A sell signal from a pivot top on January 16, 2026, resulted in an 8.67% decline, with further decreases anticipated. The stock exhibits high weekly volatility at 9.19%, with resistance at $89.16 and support at $77.55. The Price-to-Earnings ratio is negative (-235.37), signifying losses. Insider trading data indicates negative sentiment, with more selling than buying in recent transactions. A stop-loss is suggested at $83.03. For January 23, 2026, RKLB is expected to open lower at $86.24.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   23 Jan 2026, 03:56 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

4. Outcome tracking started

   02 Jul 2026, 02:14 UTC

   Tahlil Plus began monitoring the extracted predictions.

5. First prediction resolved

   02 Jul 2026, 02:14 UTC

   The first evaluable outcome in this case reached a terminal result.

6. Case evaluation completed

   02 Jul 2026, 02:14 UTC

   All evaluable predictions in this case reached terminal outcomes.